ACRS - Aclaris Therapeutics Inc. (ACRS) CEO Neal Walker on Q4 2019 Results - Earnings Call Transcript
Aclaris Therapeutics, Inc. (ACRS)
Q4 2019 Earnings Conference Call
February 25, 2020, 05:00 PM ET
Company Participants
Kamil Ali-Jackson - Chief Legal Officer
Neal Walker - President and CEO
Frank Ruffo - CFO
David Gordon - Chief Medical Officer
Joe Monahan - EVP, Research and Development
Conference Call Participants
Sudan Loganathan - Cantor Fitzgerald
Lachlan Hanbury-Brown - William Blair
Thomas Smith - SVB Leerink
Presentation
Operator
Ladies and gentlemen, thank you for standing by. And welcome to the Aclaris Therapeutics Fourth Quarter and Full Year 2019 Earnings and Business Update Call. [Operator Instructions]
I'd now